Seed, Pre-Seed
$1.0M – $5.0M
$12.6B
11+ companies
11 partners
Investment Thesis
RA Capital specializes in identifying and supporting transformative life sciences ventures, with a deep focus on biotech and innovative pharmaceuticals.
Meet the Team
Laura Stoppel is a Partner on the Investment Team at RA Capital Management. Laura works on both public and private investments and serves as a Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals. Previously, Laura covered hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. Her graduate research investigated synaptic translation in syndromic autism. Laura holds a BA in Biology and Psychology from Harvard University and a PhD in Neuroscience from MIT.
Industry Focus
Invests In
Portfolio Companies (11)
Other
Spero Therapeutics
Aimmune Therapeutics
Lusaris Therapeutics
"Discovered via firm_website (high confidence)"
Eliem Therapeutics
"Discovered via firm_website (high confidence)"
Aerovate Therapeutics
"Discovered via firm_website (high confidence)"
Imbria Pharmaceuticals
"Discovered via firm_website (high confidence)"
Athenen Therapeutics
"Discovered via firm_website (high confidence)"
RA Capital Planetary Health Fund, L.P. (CIK 0001979194)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning RA Capital Management
RA Capital Healthcare Fund LP (CIK 0001315082)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning RA Capital Management
RA Capital Planetary Health International Fund, L.P. (CIK 0001979199)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning RA Capital Management
Browse More Investors
Frequently Asked Questions
See if RA Capital Management is a match for your startup
Upload your pitch deck to see how well you match with RA Capital Management and 200+ other VC firms.